Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jack Lee

Showing results (1-10 of 441) with videos related to

Pageof 45
Sort By:
Clinical Trials (London, England)|February 5, 2015
Commentary on Hey and KimmelmanJ Jack Lee
Journal of the National Cancer Institute|December 7, 2010
Demystify statistical significance--time to move on from the p value to bayesian analysisJ Jack Lee
Statistics in Medicine|August 20, 2016
A robust two-stage design identifying the optimal biological dose for phase I/II clinical trialsYong Zang, J Jack Lee
Biometrics|September 29, 2007
A semiparametric response surface model for assessing drug interactionMaiying Kong, J Jack Lee
Chinese Clinical Oncology|April 6, 2015
Adaptive clinical trial designs in oncologyYong Zang, J Jack Lee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Randomized phase II designs in cancer clinical trials: current status and future directionsJ Jack Lee, Lei Feng
JCO Precision Oncology|February 1, 2022
A Collection of Statistical Methods for Precision OncologyYing Lu, J Jack Lee
BMC Medical Research Methodology|June 8, 2010
A simulation study for comparing testing statistics in response-adaptive randomizationXuemin Gu, J Jack Lee
Biometrical Journal. Biometrische Zeitschrift|December 4, 2018
Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomesNan Chen, J Jack Lee
Frontiers in Bioscience (Elite Edition)|December 29, 2009
Applying Emax model and bivariate thin plate splines to assess drug interactionsMaiying Kong, J Jack Lee
Pageof 45

Showing results (1-10 of 441) with videos related to

Sort By:
Pageof 45
Clinical Trials (London, England)|February 5, 2015
Commentary on Hey and KimmelmanJ Jack Lee
Journal of the National Cancer Institute|December 7, 2010
Demystify statistical significance--time to move on from the p value to bayesian analysisJ Jack Lee
Statistics in Medicine|August 20, 2016
A robust two-stage design identifying the optimal biological dose for phase I/II clinical trialsYong Zang, J Jack Lee
Biometrics|September 29, 2007
A semiparametric response surface model for assessing drug interactionMaiying Kong, J Jack Lee
Chinese Clinical Oncology|April 6, 2015
Adaptive clinical trial designs in oncologyYong Zang, J Jack Lee
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Randomized phase II designs in cancer clinical trials: current status and future directionsJ Jack Lee, Lei Feng
JCO Precision Oncology|February 1, 2022
A Collection of Statistical Methods for Precision OncologyYing Lu, J Jack Lee
BMC Medical Research Methodology|June 8, 2010
A simulation study for comparing testing statistics in response-adaptive randomizationXuemin Gu, J Jack Lee
Biometrical Journal. Biometrische Zeitschrift|December 4, 2018
Bayesian hierarchical classification and information sharing for clinical trials with subgroups and binary outcomesNan Chen, J Jack Lee
Frontiers in Bioscience (Elite Edition)|December 29, 2009
Applying Emax model and bivariate thin plate splines to assess drug interactionsMaiying Kong, J Jack Lee
Pageof 45